The effect of body temperature in the acute phase of subarachnoid hemorrhage on the long term outcome

蛛网膜下腔出血急性期体温对远期预后的影响

基本信息

  • 批准号:
    07671544
  • 负责人:
  • 金额:
    $ 0.13万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1995
  • 资助国家:
    日本
  • 起止时间:
    1995 至 1996
  • 项目状态:
    已结题

项目摘要

Background : In recent years, it has been disclosed experimentally and clinically that the brain temperature is one of the most important factors that decide the outcome of the brain disease. The purpose of this study is to evaluate the effect of the body temperature control in the acute phase of the subarachnoid hemorrage.Materials and Method : First, we developed a new SAH grading scale based solely upon the Glasgow Coma Scale and the standard outcome evaluated by Glasgow Outcome Scale with numerical translation (dead=1 to good recovery=5) for each grade. We investigated the relatioship between the SAH grade and the body temperature on the admission. Eight patients with SAH received temperature control therapy in the acute phase of the disease uwing cooling blanket to be kept at slightly hypothermic condition. The outcome was evaluated at 3 months after the onset.Results : A newly developed SAH grading is as follows ; I (GCS=15), II (GCS=11-14), III (GCS=8-10), IV (GCS=4-7), and V (GCS=3). Standard outcomes for each SAH grade are as follows respectively ; 4.68(]SY.+-。[)0.05,4.10(]SY.+-。[)0.06,3.55(]SY.+-。[)0.11,2.65(]SY.+-。[)0.10, and 1.81(]SY.+-。[)0.22. The outcome of the patients with temperature control did not exceed the standard outcome. The body temperature in the patients with low SAH grade was significantly lower than those with high SAH grade.Conclusion : These results suggest that the application of the hypothermia therapy to the patients with SAH must be done with great care in order to exceed the standard outcome.
背景:近年来,实验和临床研究表明,脑温度是决定脑病预后的重要因素之一。本研究旨在探讨体温控制在蛛网膜下腔出血急性期的作用。材料和方法:首先,我们开发了一个新的SAH分级量表,该量表完全基于格拉斯哥昏迷量表和格拉斯哥结局量表评估的标准结果,每个等级都有数字转换(死亡=1到良好恢复=5)。我们调查了入院时SAH等级与体温之间的关系。8例蛛网膜下腔出血患者在疾病急性期接受温度控制治疗,使用降温毯保持微低温状态。在发病后3个月评估结果。结果:新制定的SAH分级如下;我(GCS = 15),二(GCS = 11 - 14),三世(GCS = 8 - 10), IV (GCS = 4 - 7)和V (GCS = 3)。各SAH级别的标准结局分别如下:4.68 (SY。+ -。[0.05,4.10]SY。+ -。[0.06,3.55]SY。+ -。[0.11,2.65]SY。+ -。(0.10),和1.81 (SY。+ -。(0.22)。体温控制患者的预后未超过标准预后。低SAH分级患者的体温明显低于高SAH分级患者。结论:提示在SAH患者中应用低温治疗必须非常谨慎,才能达到超标准的疗效。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Akira Tamura: "Clinical Pharmacology of Cerebral Ischemia" Ter Horst GJ and Korf J (eds) The Humara Press Inc, (1996)
Akira Tamura:“脑缺血的临床药理学”Ter Horst GJ 和 Korf J(编辑)The Humara Press Inc,(1996)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Akira Tamura, Kiyoshi Takagi, Kensuke Kawai: "Animal models used in cerebral ischemia and stroke research. Ter Horst GJ and Korf J (eds) Clinical pharmacology of cerebral ischemia." 265-294 (1996)
Akira Tamura、Kiyoshi Takagi、Kensuke Kawai:“用于脑缺血和中风研究的动物模型。Ter Horst GJ 和 Korf J(编)脑缺血的临床药理学。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
高木清: "脳血管攣縮 vol 12" 太田富雄、浅野孝雄 他 中外医学社(in press),
Kiyoshi Takagi:《脑血管痉挛第 12 卷》Tomio Ota、Takao Asano 等(正在出版),
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Gotoh O,Tamura A,Yasui N,Suzuki A,Hadeishi H,Sano K: "Glasgow coma scale in the prediction of outcome after early aneurysm surgery" Neurosurgery. 39. 19-25 (1996)
Gotoh O,Tamura A,Yasui N,Suzuki A,Hadeishi H,Sano K:“格拉斯哥昏迷量表在预测早期动脉瘤手术后的结果中”神经外科。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Gotoh O: "Glasgow Coma Scule in the Prediction of Outcome after Eary Aneurysm Surgery" Neurosurgery. 39. 19-25 (1996)
Gotoh O:“格拉斯哥昏迷 Scule 在预测耳动脉瘤手术后的结果”神经外科。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKAGI Kiyoshi其他文献

TAKAGI Kiyoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKAGI Kiyoshi', 18)}}的其他基金

Possible involvement of intratumoral androgens in breast cancer immune microenvironment
瘤内雄激素可能参与乳腺癌免疫微环境
  • 批准号:
    19K07410
  • 财政年份:
    2019
  • 资助金额:
    $ 0.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Modification of estrogen action of breast cancer by tumor-associated immune cells
肿瘤相关免疫细胞对乳腺癌雌激素作用的改变
  • 批准号:
    26860229
  • 财政年份:
    2014
  • 资助金额:
    $ 0.13万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Estrogens in male breast carcinoma
雌激素在男性乳腺癌中的作用
  • 批准号:
    24790343
  • 财政年份:
    2012
  • 资助金额:
    $ 0.13万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)

相似海外基金

Non-invasive vagus nerve stimulation to mitigate subarachnoid hemorrhage induced inflammation
无创迷走神经刺激减轻蛛网膜下腔出血引起的炎症
  • 批准号:
    10665166
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
Role of a novel hypothalamic protein SRPX2 in hypothalamic injury after subarachnoid hemorrhage
新型下丘脑蛋白SRPX2在蛛网膜下腔出血后下丘脑损伤中的作用
  • 批准号:
    23K15671
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Nimodipine Systemic Exposure and Outcomes Following Aneurysmal Subarachnoid Hemorrhage: A Prospective Multi-centre Observational Study (ASH-II Study)
尼莫地平全身暴露和动脉瘤性蛛网膜下腔出血后的结果:一项前瞻性多中心观察研究(ASH-II 研究)
  • 批准号:
    494000
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
    Operating Grants
Electroencephalographic signatures of dysfunctional cerebrovascular autoregulation as biomarkers of brain injury in aneurysmal subarachnoid hemorrhage (SAH)
脑血管自动调节功能障碍的脑电图特征作为动脉瘤性蛛网膜下腔出血(SAH)脑损伤的生物标志物
  • 批准号:
    10667162
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
Development of a 3D neurovascular unit for in vitro modeling of subarachnoid hemorrhage and screening therapies
开发用于蛛网膜下腔出血体外建模和筛选治疗的 3D 神经血管单元
  • 批准号:
    10722387
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
Development of novel drugs for subarachnoid hemorrhage focusing on ferroptosis
以铁死亡为重点的蛛网膜下腔出血新药开发
  • 批准号:
    23K15661
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Roles of NAMPT and NAD+ in hypoxic conditioning-induced neurovascular protection in subarachnoid hemorrhage
NAMPT和NAD在蛛网膜下腔出血低氧条件诱导的神经血管保护中的作用
  • 批准号:
    10660398
  • 财政年份:
    2023
  • 资助金额:
    $ 0.13万
  • 项目类别:
GPR39 as a Therapeutic Target in Subarachnoid Hemorrhage (SAH)
GPR39 作为蛛网膜下腔出血 (SAH) 的治疗靶点
  • 批准号:
    10478533
  • 财政年份:
    2022
  • 资助金额:
    $ 0.13万
  • 项目类别:
A Novel Targeted Therapy for Subarachnoid Hemorrhage
蛛网膜下腔出血的新型靶向治疗
  • 批准号:
    10385590
  • 财政年份:
    2022
  • 资助金额:
    $ 0.13万
  • 项目类别:
The Use of Deferiprone to Improve Subarachnoid Hemorrhage Cognitive Outcome: U-DISCO
使用去铁酮改善蛛网膜下腔出血的认知结果:U-DISCO
  • 批准号:
    10677785
  • 财政年份:
    2022
  • 资助金额:
    $ 0.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了